Investors
Information Disclosure
-
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.05.24
-
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.05.23
-
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR MARKETING OF CATEGORY I INNOVATIVE DRUG “TQ-B3139”2022.05.23
-
REPURCHASE OF EURO750,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 20252022.05.23
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.05.20
-
CHANGE OF VENUE OF ANNUAL GENERAL MEETING AND SPECIAL ARRANGEMENTS FOR ANNUAL GENERAL MEETING2022.05.20
-
REPURCHASE OF EURO750,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 20252022.05.20
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.05.19